TRYPSIN 0.25% (1X) Solution, with 2.5 g

Cytiva Austria

Revision date : 2021-01-30

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2021-01-30

Product name

TRYPSIN 0.25% (1X) Solution, with 2.5 g

CAS No.

9002-07-7

1.2.1 Relevant identified uses

For Further Manufacturing or Research Use. Not for Diagnostic or Therapeutic Use

supplier name

Cytiva Austria

Icons in SDS

Company Information

company name

Cytiva Austria

GHS Information

Signal word

Danger

Section 2

2.1 Classification of the substance or mixture

according to GB 13690-2009 and GB 30000-2013 Emergency overview Liquid. Clear. Reddish May cause allergy or asthma symptoms or breathing difficulties if inhaled. If experiencing respiratory symptoms: Call a POISON CENTER or physician. See Section 12 for environmental precautions. RESPIRATORY SENSITIZATION - Category 1 or mixture

Signal word

Danger

Hazard statements

May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Prevention

Wear respiratory protection. Avoid breathing vapor.

Response

IF INHALED: Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or physician.

Storage

Not applicable.

Disposal

Dispose of contents and container in accordance with all local, regional, national and international regulations.

Other physicochemical hazards

No known significant effects or critical hazards.

Health hazards

May cause allergy or asthma symptoms or breathing difficulties if inhaled. Symptoms related to the physical, chemical and toxicological characteristics Eye contact No specific data. Inhalation Adverse symptoms may include the following: wheezing and breathing difficulties asthma Skin contact No specific data. Ingestion No specific data. Delayed and immediate effects and also chronic effects from short and long term exposure Short term exposure Potential immediate effects Not available. Potential delayed effects Not available. Long term exposure Potential immediate effects Not available. Potential delayed effects Not available.

Environmental hazards

No known significant effects or critical hazards.

Other hazards which do not result in classification

None known.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.